Skip to content

Company information lookup

BIOXYNE LIMITED (BXN)

Biotechnology.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BXN 0.009 80% 0.005 0.009 0.007 0.009 0.007 704,850

BIOXYNE LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BXN
Securities
Official Listing Date 14 December, 2000
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.bioxyne.com
Registered Office Address Traverse Accountants, Level 4, 25 Lime Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone (02) 8296 0000
Head Office Fax (02) 9844 5445
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 4, 60 CARRINGTON STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Anthony Peng Ho (Chairman, Non Exec. Director)
Mr Jeremy Laurence Curnock Cook (Non Exec. Director)
Mr Patrick Ford (Non Exec. Director)
Mr Jarrod Travers White (CFO)
Company Secretary Mr Jarrod Travers White
Principal Activities Biotechnology.

BIOXYNE LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
04/04/2014   Appendix 3B - Quotation Following ASX Escrow Release 14 PDF
01/04/2014   Change of Director's Interest Notice - P Ford 2 PDF
18/03/2014   Release of Shares from Escrow 1 PDF
28/02/2014 asterix Half Yearly Report and Accounts 19 PDF
25/02/2014   Change of Director's Interest Notice - P Ford 2 PDF
25/02/2014   Completion of the Sale of HI-164 Program 2 PDF
19/02/2014   Change of Director's Interest Notice - P Ford 2 PDF
14/02/2014   Change in substantial holding 2 PDF
31/01/2014 asterix Appendix 4C - December Quarterly 7 PDF
31/01/2014   Amended Change of Director's Interest Notices 7 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 Apr 2014 0.009 80% 0.009 0.007 704,850
16 Apr 2014 0.005 -28.57% 0.005 0.005 636,364
14 Apr 2014 0.007 -12.5% 0.007 0.007 200,000
10 Apr 2014 0.008 14.29% 0.008 0.008 100,000
09 Apr 2014 0.007 0% 0.007 0.007 153,500

* Volume of shares shown represents only those shares traded on ASX.

BIOXYNE LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BXN. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BXN

Warrants & Structured Products

No warrants & Structured Products are available over the security BXN

ASX CFDs

No Contracts For Differences are available over the security BXN